When the government promotes the use of traditional drugs in combination with Qingwen, Chinese people loudly call for acetaminophen

There are disagreements between the public and experts regarding the effectiveness of lianhua qingwen jiaonang as a treatment method, and regulatory agencies in some countries have warned against its use or even banned its use, such as the US Food and Drug Administration (FDA).

Hong Kong: According to media reports on Sunday, as people infected with COVID-19 in China request to take ibuprofen and paracetamol, the government is promoting a traditional drug called Lianhuawen to control the surge of COVID-19 infection.

According to the South China Morning Post, there are differences between people and experts regarding its effectiveness as a treatment method, and regulatory agencies in some countries have warned against its use or even banned its use, such as the US Food and Drug Administration (FDA).

Why give us expensive Lianhua English? What we need are drugs that can lower body temperature, such as ibuprofen and paracetamol

According to reports, some provinces are distributing tens of thousands of boxes containing Lianhua Qingwen to residents. At the beginning of the COVID-19 epidemic, the government officially recommended this drug as a treatment.

Why can Lianhua Qingwen be freely transported and distributed, while the usual fever reducing drugs are not supplied and distributed Another Weibo user asked.

The Yunnan Provincial Government has stated that there is a serious shortage of ibuprofen and paracetamol, and the government is working to make them produce at "full capacity".

Lianhua Qingwen was included in the National Covid-19 Guidelines in April 2020 as a recommended treatment for mild to moderate cases of fever, cough, and fatigue, becoming a well-known name. Earlier this year. The report states that it was included in the epidemic prevention kit distributed to every household in Hong Kong during the fight against the surge in cases.

However, Liu Qingquan, president of the Beijing Hospital of Traditional Chinese Medicine, said at the press conference that "COVID-19 can have more choices" according to the theory of simultaneous treatment of different diseases. The choice of drugs is actually very broad, and all of these drugs can treat infections caused by Omicron mutations

Chinese officials estimate that in the first 20 days of December, approximately 250 million people (18% of the Chinese population) were infected with Covid-19, as Beijing suddenly lifted restrictions on controlling the disease for nearly three years.